All Stories

  1. Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015

    Article • Infection and Drug Resistance, August 2018, Dove Medical Press

    Dr Kamal Hamed, Anne Santerre Henriksen

  2. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection

    Article • Therapeutic Advances in Respiratory Disease, June 2017, SAGE Publications

    Dr Kamal Hamed

  3. Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients

    Article • Hepatology Research, June 2017, Wiley

    Dr Kamal Hamed

  4. Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data

    Article • Patient Preference and Adherence, April 2017, Dove Medical Press

    Dr Kamal Hamed

  5. Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data

    Article • Therapeutic Advances in Infectious Disease, February 2017, SAGE Publications

    Dr Kamal Hamed

  6. Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence

    Article • Therapeutic Advances in Respiratory Disease, February 2017, SAGE Publications

    Dr Kamal Hamed

  7. Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model

    Article • Journal of Gastroenterology and Hepatology, January 2017, Wiley

    Dr Kamal Hamed

  8. Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria

    Article • Antimicrobial Agents and Chemotherapy, November 2016, ASM Journals

    Dr Kamal Hamed

  9. Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy

    Article • British Journal of Clinical Pharmacology, October 2016, Wiley

    Dr Kamal Hamed

  10. Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

    Article • Infection and Drug Resistance, April 2016, Dove Medical Press

    Dr Kamal Hamed

  11. No Robust Evidence of Lumefantrine Resistance

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Dr Kamal Hamed